NeuroPace (NASDAQ:NPCE) Price Target Cut to $15.00 by Analysts at Wells Fargo & Company - MarketBeat
12 hours ago • Google News
NeuroPace, Inc. operates as a medical device company in the United States.
12 hours ago • Google News
5 days ago • Google News